Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Widely Chemical Technology Co., Ltd. is a specialized high-tech enterprise focused on the research, development, and large-scale production of pharmaceutical raw materials and intermediates. Based in Wuhan, China, the company has established itself as a significant supplier of Active Pharmaceutical Ingredients (APIs), particularly in the fields of steroids, hormones, and vitamins. Their product portfolio includes a wide range of compounds such as glucocorticoids, androgens, and various nutritional additives. The company operates modern manufacturing facilities that adhere to international quality standards, providing services to the global pharmaceutical, biotech, and fine chemical industries. In addition to catalog products, Hubei Widely Chemical offers custom synthesis and contract manufacturing (CMO) services to support drug development from pilot scale to commercial production. Their strategic location in the Optics Valley of China allows them to leverage regional technical expertise and logistics for international export.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Widely Chemical.